Clinical Drug Investigation

, Volume 24, Issue 12, pp 765–769 | Cite as

Cerebral Blood Flow before and after Treatment with Amlodipine in Elderly Patients with Lacunar Infarction

  • Toshio Imaizumi
  • Masahiko Chiba
  • Toshimi Honma
  • Junpei Yoshikawa
  • Jun Niwa
Short Communication

Keywords

Ischaemic Stroke Single Photon Emission Compute Tomography Cerebral Blood Flow Amlodipine Blood Pressure Reduction 

Notes

Acknowledgements

The study received no funding and the authors have no conflicts of interest directly relevant to the content of the study.

References

  1. 1.
    Eames PJ, Blake MJ, Dawson SL, et al. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2002; 72(4): 467–72PubMedGoogle Scholar
  2. 2.
    Leonardi-Bee J, Bath PM, Phillips SJ, et al. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33(5): 1315–20PubMedCrossRefGoogle Scholar
  3. 3.
    Meyer JS, Shimazu K, Fukuuchi Y, et al. Impaired neurogenic cerebrovascular control and dysautoregulation after stroke. Stroke 1973; 4(2): 169–86PubMedCrossRefGoogle Scholar
  4. 4.
    Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350(9080): 757–64PubMedCrossRefGoogle Scholar
  5. 5.
    Irie K, Yamaguchi T, Minematsu K, et al. The J-curve phenomenon in stroke recurrence. Stroke 1993; 24(12): 1844–9PubMedCrossRefGoogle Scholar
  6. 6.
    Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351(9118): 1755–62PubMedCrossRefGoogle Scholar
  7. 7.
    Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity. The Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354(9192): 1751–6PubMedCrossRefGoogle Scholar
  8. 8.
    MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease: part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335(8692): 765–74PubMedCrossRefGoogle Scholar
  9. 9.
    The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288(23): 2981–97CrossRefGoogle Scholar
  10. 10.
    PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358(9287): 1033–41CrossRefGoogle Scholar
  11. 11.
    Schrader J, Luders S, Kulschewski A, et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34(7): 1699–703PubMedCrossRefGoogle Scholar
  12. 12.
    Bath P, Chalmers J, Powers W, et al. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003; 21(4): 665–72PubMedCrossRefGoogle Scholar
  13. 13.
    Cochrane Stroke Group. Interventions for deliberately altering blood pressure in acute stroke. Blood pressure in Acute Stroke Collaboration (BASC). Cochrane Database Syst Rev 2000 (2): CD000039Google Scholar
  14. 14.
    Hinton RC. Manual of neurologic therapeutics. 5th ed. Boston (MA): Littlebrown and Company, 1995: 207–23Google Scholar
  15. 15.
    Guidelines Subcommittee of the Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension. Kyorinnsya 2000, 45-54Google Scholar
  16. 16.
    Cai H, Yao H, Ibayashi S, et al. Amlodipine, a Ca2+ channel antagonist, modifies cerebral blood flow autoregulation in hypertensive rats. Eur J Pharmacol 1996; 313(1–2): 103–6PubMedCrossRefGoogle Scholar
  17. 17.
    Pandita-Gunawardena ND, Clarke SE. Amlodipine lowers blood pressure without affecting cerebral blood flow as measured by single photon emission computed tomography in elderly hypertensive subjects. Age Ageing 1999; 28(5): 451–7PubMedCrossRefGoogle Scholar
  18. 18.
    Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000; 102(13): 1503–10PubMedCrossRefGoogle Scholar
  19. 19.
    Oishi M, Mochizuki Y, Hara M, et al. Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarction. Clin Neuropharmacol 1996; 19(6): 526–31PubMedCrossRefGoogle Scholar
  20. 20.
    Kaminaga T, Kunimatsu N, Chikamatsu T, et al. Validation of CBF measurement with non-invasive microsphere method (NIMS) compared with autoradiography method (ARG). Ann Nucl Med 2001; 15(1): 61–4PubMedCrossRefGoogle Scholar
  21. 21.
    Kalimo H, Kaste M, Haltia M. Hypertensive angiopathy. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. 6th ed. London: Arnold Publishers, 1997: 325–31Google Scholar
  22. 22.
    Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. Am J Neuroradiol 1999; 20(4): 637–42PubMedGoogle Scholar
  23. 23.
    PerryJr HM, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284(4): 465–71PubMedCrossRefGoogle Scholar
  24. 24.
    Nishizawa S, Shiozaki T, Ueno M, et al. A new method to estimate rCBF using IMP and SPECT without any blood sampling. Ann Nucl Med 2000; 14(6): 433–40PubMedCrossRefGoogle Scholar
  25. 25.
    Bill A, Linder J. Sympathetic control of cerebral blood flow in acute arterial hypertension. Acta Physiol Scand 1976; 96(1): 114–21PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Toshio Imaizumi
    • 1
  • Masahiko Chiba
    • 1
  • Toshimi Honma
    • 1
  • Junpei Yoshikawa
    • 1
  • Jun Niwa
    • 1
  1. 1.Hakodate Municipal Hospital, HakodateHokkaidoJapan

Personalised recommendations